Rapid identification of pathogens using molecular techniques

Pathology

Volumn 47, Issue 3, 2015, Pages 191-198

  Sloots, Theo P ^a,b   Nissen, Michael D ^a,b   Ginn, Andrew N ^c,d   Iredell, Jonathan R ^c,d  

^a LADY CILENTO CHILDREN S HOSPITAL   (Australia)

^b Microbiology Department   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d University of Sydney   (Australia)

Author keywords

Antimicrobial resistance; clinical microbiology; nucleic acid testing; rapid diagnostics; real time PCR

Indexed keywords

HUMAN; MASS SPECTROMETRY; MICROBIOLOGICAL EXAMINATION; MOLECULAR DIAGNOSIS; PROCEDURES; REAL TIME POLYMERASE CHAIN REACTION;

HUMANS; MICROBIOLOGICAL TECHNIQUES; MOLECULAR DIAGNOSTIC TECHNIQUES; REAL-TIME POLYMERASE CHAIN REACTION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84952715793     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1097/PAT.0000000000000241     Document Type: Article

References (133)

1. 1. Espy, M.J., Uhl, J.R., Sloan, L.M., et al. Real-time PCR in clinical microbiology: applications for routine laboratory testing. Clin Microbiol Rev 19 (2006), 165–256.
2. 2. Prosperi, M.C.F., Yin, L., Nolan, D.J., et al. Empirical validation of viral quasispecies assembly algorithms: state-of-the-art and challenges. Sci Rep, 3, 2013, 3827.
3. 3. Reuter, S., Ellington, M.J., Cartwright, E.J., et al. Rapid bacterial whole-genome sequencing to enhance diagnostic and public health microbiology. JAMA Intern Med 173 (2013), 1397–1404.
4. 4. Barzon, L., Lavezzo, E., Militello, V., et al. Applications of next-generation sequencing technologies to diagnostic virology. Int J Mol Sci 12 (2011), 7861–7884.
5. 5. Prosperi, M.C., Salemi, M., QuRe: Software for viral quasispecies reconstruction from next-generation sequencing data. Bioinformatics 28 (2012), 132–133.
6. 6. Robinson, E.R., Walker, T.M., Pallen, M.J., Genomics and outbreak investigation: from sequence to consequence. Genome Med, 5, 2013, 36.
7. 7. Dobrindt, U., Hacker, J., Whole genome plasticity in pathogenic bacteria. Curr Opin Microbiol 4 (2001), 550–557.
8. 8. Whiley, D.M., Bialasiewicz, S., Bletchly, C., et al. Detection of novel influenza A(H1N1) virus by real-time RT-PCR. J Clin Virol 45 (2009), 203–204.
9. 9. Whiley, D.M., Jacob, K., Nakos, J., et al. Improved detection of genetic markers of antimicrobial resistance by hybridization probe-based melting curve analysis using primers to mask proximal mutations: examples include the influenza H275Y substitution. J Antimicrob Chemother 67 (2012), 1375–1379.
10. 10. Webb, S.A., Pettila, V., Seppelt, I., et al. Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med 361 (2009), 1925–1934.
11. 11. Blyth, C.C., Iredell, J.R., Dwyer, D.E., Rapid-test sensitivity for novel swineorigin influenza A (H1N1) virus in humans. N Engl J Med, 361, 2009, 2493.
12. 12. Hackett, H., Bialasiewicz, S., Jacob, K., et al. Screening for H7N9 influenza A by matrix gene-based real-time reverse-transcription PCR. J Virol Methods 195 (2014), 123–125.
13. 13. Ellem, J., Partridge, S.R., Iredell, J.R., Efficient direct extended-spectrum β-lactamase detection by multiplex real-time PCR: accurate assignment of phenotype by use of a limited set of genetic markers. J Clin Microbiol 49 (2011), 3074–3077.
14. 14. Morinaga, Y., Yanagihara, K., Broad-range PCR in the identification of bacterial and fungal pathogens from positive blood culture bottles: a sequencing approach. Methods Mol Biol 1237 (2015), 65–72.
15. 15. Tang, Y.W., Kilic, A., Yang, Q., et al. StaphPlex system for rapid and simultaneous identification of antibiotic resistance determinants and Panton-Valentine leukocidin detection of staphylococci from positive blood cultures. J Clin Microbiol 45 (2007), 1867–1873.
16. 16. Werner, G., Serr, A., Schutt, S., et al. Comparison of direct cultivation on a selective solid medium, polymerase chain reaction from an enrichment broth, and the BD GeneOhm VanR Assay for identification of vancomycin-resistant enterococci in screening specimens. Diagn Microbiol Infect Dis 70 (2011), 512–521.
17. 17. Fredricks, D.N., Relman, D.A., Improved amplification of microbial DNA from blood cultures by removal of the PCR inhibitor sodium polyanetho-lesulfonate. J Clin Microbiol 36 (1998), 2810–2816.
18. 18. Akane, A., Matsubara, K., Nakamura, H., et al. Identification of the heme compound copurified with deoxyribonucleic acid (DNA) from bloodstains, a major inhibitor of polymerase chain reaction (PCR) amplification. J Forensic Sci 39 (1994), 362–372.
19. 19. Regan, J.F., Furtado, M.R., Brevnov, M.G., et al. A sample extraction method for faster, more sensitive PCR-based detection of pathogens in blood culture. J Mol Diagn 14 (2012), 120–129.
20. 20. Edwards, K.J., Logan, J.M., Langham, S., et al. Utility of real-time amplification of selected 16S rRNA gene sequences as a tool for detection and identification of microbial signatures directly from clinical samples. J Med Microbiol 61 (2012), 645–652.
21. 21. Kirkbright, S., Fatovich, D., Kee, C., et al. Quantitative rt-PCR holds promise as a screening tool for patients with severe sepsis. Emerg Med Australas 23 (2011), 502–506.
22. 22. Kommedal, O., Simmon, K., Karaca, D., et al. Dual priming oligonucleotides for broad-range amplification of the bacterial 16S rRNA gene directly from human clinical specimens. J Clin Microbiol 50 (2012), 1289–1294.
23. 23. Sontakke, S., Cadenas, M.B., Maggi, R.G., et al. Use of broad range 16S rDNA PCR in clinical microbiology. J Microbiol Methods 76 (2009), 217–225.
24. 24. Lyra, J.M., Maruza, M., Verza, M., et al. Evaluation of four molecular methods for the diagnosis of tuberculosis in pulmonary and blood samples from immunocompromised patients. Mem Inst Oswaldo Cruz 109 (2014), 805–813.
25. 25. Michou, I.V., Constantoulakis, P., Makarounis, K., et al. Molecular investigation of menstrual tissue for the presence of Chlamydia trachomatis, Ureaplasma urealyticum and Mycoplasma hominis collected by women with a history of infertility. J Obstet Gynaecol Res 40 (2014), 237–242.
26. 26. Barbee, L.A., Dombrowski, J.C., Kerani, R., et al. Effect of nucleic acid amplification testing on detection of extragenital gonorrhea and chlamydial infections in men who have sex with men sexually transmitted disease clinic patients. Sex Transm Dis 41 (2014), 168–172.
27. 27. Thomas, L.C., Gidding, H.F., Ginn, A.N., et al. Development of a real-time Staphylococcus aureus and MRSA (SAM-) PCR for routine blood culture. J Microbiol Methods 68 (2007), 296–302.
28. 28. van Hal, S.J., Stark, D., Lockwood, B., et al. Methicillin-resistant Staphylococcus aureus (MRSA) detection: comparison of two molecular methods (IDI-MRSA PCR assay and GenoType MRSA Direct PCR assay) with three selective MRSA agars (MRSA ID, MRSASelect, and CHROMagar MRSA) for use with infection-control swabs. J Clin Microbiol 45 (2007), 2486–2490.
29. 29. Banks, J.T., Bharara, S., Tubbs, R.S., et al. Polymerase chain reaction for the rapid detection of cerebrospinal fluid shunt or ventriculostomy infections. Neurosurgery 57 (2005), 1237–1243.
30. 30. Wang, H.Y., Kim, S., Kim, J., et al. Multiplex real-time PCR assay for rapid detection of methicillin-resistant staphylococci directly from positive blood cultures. J Clin Microbiol 52 (2014), 1911–1920.
31. 31. Al-Mohri, H.A., Tadros, M.A., Louie, L., et al. Utility of direct, real-time PCR in the management of a nosocomial outbreak of vancomycin-resistant Enterococcus faecium (vanB genotype). Eur J Clin Microbiol Infect Dis 27 (2008), 321–322.
32. 32. Cekin, Y., Erman Daloglu, A., Ogunc, D., et al. Evaluation of vancomycin resistance 3 multiplexed PCR assay for detection of vancomycin-resistant enterococci from rectal swabs. Ann Lab Med 33 (2013), 326–330.
33. 33. Zhou, X., Arends, J.P., Kampinga, G.A., et al. Evaluation of the Xpert vanA/vanB assay using enriched inoculated broths for direct detection of vanB vancomycin-resistant enterococci. J Clin Microbiol 52 (2014), 4293–4297.
34. 34. Roisin, S., Laurent, C., Denis, O., et al. Impact of rapid molecular screening at hospital admission on nosocomial transmission of methicillin-resistant Staphylococcus aureus: cluster randomised trial. PLoS One, 9, 2014, e96310.
35. 35. Hombach, M., Pfyffer, G.E., Roos, M., et al. Detection of methicillin-resistant Staphylococcus aureus (MRSA) in specimens from various body sites: performance characteristics of the BD GeneOhm MRSA assay, the Xpert MRSA assay, and broth-enriched culture in an area with a low prevalence of MRSA infections. J Clin Microbiol 48 (2010), 3882–3887.
36. 36. Laurent, C., Bogaerts, P., Schoevaerdts, D., Evaluation of the Xpert MRSA assay for rapid detection of methicillin-resistant Staphylococcus aureus from nares swabs of geriatric hospitalized patients and failure to detect a specific SCCmec type IV variant. Eur J Clin Microbiol Infect Dis 29 (2010), 995–1002.
37. 37. Patel, P.A., Ledeboer, N.A., Ginocchio, C.C., et al. Performance of the BD GeneOhm MRSA achromopeptidase assay for real-time PCR detection of methicillin-resistant Staphylococcus aureus in nasal specimens. J Clin Microbiol 49 (2011), 2266–2268.
38. 38. Chan, W.S., Chan, T.M., Lai, T.W., et al. Complementary use of MALDI-TOF MS and real-time PCR-melt curve analysis for rapid identification of methicillin-resistant staphylococci and VRE. J Antimicrob Chemother 70 (2015), 441–447.
39. 39. Clerc, O., Prod'hom, G., Senn, L., et al. Matrix-assisted laser desorption ionization time-of-flight mass spectrometry and PCR-based rapid diagnosis of Staphylococcus aureus bacteraemia. Clin Microbiol Infect 20 (2014), 355–360.
40. 40. Syrmis, M.W., Moser, R.J., Whiley, D.M., et al. Comparison of a multiplexed MassARRAY system with real-time allele-specific PCR technology for genotyping of methicillin-resistant Staphylococcus aureus. Clin Microbiol Infect 17 (2011), 1804–1810.
41. 41. Leopold, S.R., Goering, R.V., Witten, A., et al. Bacterial whole-genome sequencing revisited: portable, scalable, and standardized analysis for typing and detection of virulence and antibiotic resistance genes. J Clin Microbiol 52 (2014), 2365–2370.
42. 42. Salipante, S.J., SenGupta, D.J., Cummings, L.A., et al. Application of whole genome sequencing for bacterial strain typing in molecular epidemiology. J Clin Microbiol, 2015.
43. 43. Gosiewski, T., Flis, A., Sroka, A., et al. Comparison of nested, multiplex, qPCR; FISH; SeptiFast and blood culture methods in detection and identification of bacteria and fungi in blood of patients with sepsis. BMC Microbiol, 14, 2014, 2323.
44. 44. Trebesius, K., Leitritz, L., Adler, K., et al. Culture independent and rapid identification of bacterial pathogens in necrotising fasciitis and strepto-coccal toxic shock syndrome by fluorescence in situ hybridisation. Med Microbiol Immunol 188 (2000), 169–175.
45. 45. Kok, J., Thomas, L.C., Olma, T., et al. Identification of bacteria in blood culture broths using matrix-assisted laser desorption-ionization Sepsityper and time of flight mass spectrometry. PLoS One, 6, 2011, e23285.
46. 46. Ferreira, L., Sanchez-Juanes, F., Gonzalez-Avila, M., et al. Direct identification of urinary tract pathogens from urine samples by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol 48 (2010), 2110–2115.
47. 47. Kok, J., Chen, S.C., Dwyer, D.E., et al. Current status of matrix-assisted laser desorption ionisation-time of flight mass spectrometry in the clinical microbiology laboratory. Pathology 45 (2013), 4–17.
48. 48. Oliveira, K., Procop, G.W., Wilson, D., et al. Rapid identification of Staphylococcus aureus directly from blood cultures by fluorescence in situ hybridization with peptide nucleic acid probes. J Clin Microbiol 40 (2002), 247–251.
49. 49. Burckhardt, I., Zimmermann, S., Using matrix-assisted laser desorption ionization-time of flight mass spectrometry to detect carbapenem resistance within 1 to 2. 5 hours. J Clin Microbiol 49 (2011), 3321–3324.
50. 50. Hrabak, J., Walkova, R., Studentova, V., et al. Carbapenemase activity detection by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol 49 (2011), 3222–3227.
51. 51. Hrabak, J., Studentova, V., Walkova, R., et al. Detection of NDM-1, VIM-1, KPC, OXA-48, and OXA-162 carbapenemases by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol 50 (2012), 2441–2443.
52. 52. Sparbier, K., Schubert, S., Weller, U., et al. Matrix-assisted laser desorption ionization-time of flight mass spectrometry-based functional assay for rapid detection of resistance against β-lactam antibiotics. J Clin Microbiol 50 (2012), 927–937.
53. 53. Lee, Y.H., Cho, B., Bae, I.K., et al. Klebsiella pneumoniae strains carrying the chromosomal SHV-11 β-lactamase gene produce the plasmid-mediated SHV-12 extended-spectrum β-lactamase more frequently than those carrying the chromosomal SHV-1 β-lactamase gene. J Antimicrob Chemother 57 (2006), 1259–1261.
54. 54. Nuesch-Inderbinen, M.T., Kayser, F.H., Hachler, H., Survey and molecular genetics of SHV β-lactamases in Enterobacteriaceae in Switzerland: two novel enzymes, SHV-11 and SHV-12. Antimicrob Agents Chemother 41 (1997), 943–949.
55. 55. Ginn, A.N., Wiklendt, A.M., Zong, Z., et al. Prediction of major antibiotic resistance in Escherichia coli and Klebsiella pneumoniae in Singapore, USA and China using a limited set of gene targets. Int J Antimicrob Agents 43 (2014), 563–565.
56. 56. Ginn, A.N., Zong, Z., Wiklendt, A.M., et al. Limited diversity in the gene pool allows prediction of third-generation cephalosporin and aminoglycoside resistance in Escherichia coli and Klebsiella pneumoniae. Int J Antimicrob Agents 42 (2013), 19–26.
57. 57. Kohl, T.A., Diel, R., Harmsen, D., et al. Whole-genome-based Mycobacterium tuberculosis surveillance: a standardized, portable, and expandable approach. J Clin Microbiol 52 (2014), 2479–2486.
58. 58. Walker, T.M., Ip, C.L., Harrell, R.H., et al. Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study. Lancet Infect Dis 13 (2013), 137–146.
59. 59. Deplano, A., Denis, O., Nonhoff, C., et al. Outbreakof hospital-adapted clonal complex-17 vancomycin-resistant Enterococcus faecium strain in a haematology unit: role of rapid typing for early control. J Antimicrob Chemother 60 (2007), 849–854.
60. DHA-1 in a neonatal intensive care unit in China. J Med Microbiol 61 (2012), 984–989.
61. 61. Sabat, A., Krzyszton-Russjan, J., Strzalka, W., et al. New method for typing Staphylococcus aureus strains: multiple-locus variable-number tandem repeat analysis of polymorphism and genetic relationships of clinical isolates. J Clin Microbiol 41 (2003), 1801–1804.
62. 62. Chin, C.S., Sorenson, J., Harris, J.B., et al. The origin of the Haitian cholera outbreak strain. N Engl J Med 364 (2011), 33–42.
63. 63. Grad, Y.H., Lipsitch, M., Feldgarden, M., et al. Genomic epidemiology of the Escherichia coli O104:H4 outbreaks in Europe, 2011. Proc Natl Acad Sci USA 109 (2012), 3065–3070.
64. 64. Sabat, A.J., Budimir, A., Nashev, D., et al. Overview of molecular typing methods for outbreak detection and epidemiological surveillance. Euro Surveill, 18, 2013, 20380.
65. 65. Outbreak of Escherichia coli O104:H4 infections associated with sprout consumption - Europe and North America, May-July 2011. MMWR Morb Mortal Wkly Rep 2013; 62: 1029–31.
66. 66. Cantey, J.B., Sreeramoju, P., Jaleel, M., et al. Prompt control of an outbreak caused by extended-spectrum β-lactamase–producing Klebsiella pneumoniae in a neonatal intensive care unit. J Pediatr 163 (2013), 672–679.
67. 67. Snitkin, E.S., Zelazny, A.M., Thomas, P.J., et al. Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing. Sci Transl Med, 4, 2012, 148ra16.
68. 68. Smit, E., Antiviral resistance testing. Curr Opin Infect Dis 27 (2014), 566–572.
69. 69. Andrei, G., Georgala, A., Topalis, D., et al. Heterogeneity and evolution of thymidine kinase and DNA polymerase mutants of herpes simplex virus type 1: implications for antiviral therapy. J Infect Dis 207 (2013), 1295–1305.
70. 70. Andrei, G., Snoeck, R., Herpes simplex virus drug-resistance: new mutations and insights. Curr Opin Infect Dis 26 (2013), 551–560.
71. 71. Andrei, G., Topalis, D., Fiten, P., et al. In vitro-selected drug-resistant varicella-zoster virus mutants in the thymidine kinase and DNA poly-merase genes yield novel phenotype-genotype associations and highlight differences between antiherpesvirus drugs. J Virol 86 (2012), 2641–2652.
72. 72. Sauerbrei, A., Bohn, K., Phenotypic and genotypic testing of HSV-1 resistance to antivirals. Methods Mol Biol 1144 (2014), 149–165.
73. 73. Capobianchi, M.R., Giombini, E., Rozera, G., Next-generation sequencing technology in clinical virology. Clin Microbiol Infect 19 (2013), 15–22.
74. 74. Wang, C., Mitsuya, Y., Gharizadeh, B., et al. Characterization of mutation spectra with ultra-deep pyrosequencing: application to HIV-1 drug resistance. Genome Res 17 (2007), 1195–1201.
75. 75. Burke, D.S., Recombination in HIV: an important viral evolutionary strategy. Emerg Infect Dis 3 (1997), 253–259.
76. 76. Shao, W., Boltz, V.F., Spindler, J.E., et al. Analysis of 454 sequencing error rate, error sources, and artifact recombination for detection of Low-frequency drug resistance mutations in HIV-1 DNA. Retrovirology, 10, 2013, 18.
77. 77. Stekler, J.D., Ellis, G.M., Carlsson, J., et al. Prevalence and impact of minority variant drug resistance mutations in primary HIV-1 infection. PLoS One, 6, 2011, e28952.
78. 78. Gianella, S., Richman, D.D., Minority variants of drug-resistant HIV. J Infect Dis 202 (2010), 657–666.
79. 79. Schwaber, M.J., Carmeli, Y., Mortality and delay in effective therapy associated with extended-spectrum β-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. J Antimicrob Chemother 60 (2007), 913–920.
80. 80. Cortes, J.A., Garzon, D.C., Navarrete, J.A., et al. Impact of inappropriate antimicrobial therapy on patients with bacteremia in intensive care units and resistance patterns in Latin America. Rev Argent Microbiol 42 (2010), 230–234.
81. 81. Lupei, M.I., Mann, H.J., Beilman, G.J., et al. Inadequate antibiotic therapy in solid organ transplant recipients is associated with a higher mortality rate. Surg Infect (Larchmt) 11 (2010), 33–39.
82. 82. Peralta, G., Sanchez, M.B., Garrido, J.C., et al. Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia. J Antimicrob Chemother 60 (2007), 855–863.
83. 83. Bourdon, N., Berenger, R., Lepoultier, R., et al. Rapid detection of vanco-mycin-resistant enterococci from rectal swabs by the Cepheid Xpert vanA/ vanB assay. Diagn Microbiol Infect Dis 67 (2010), 291–293.
84. 84. Jiang, X., Espedido, B.A., Partridge, S.R., et al. Paradoxical effect of Klebsiella pneumoniae OmpK36 porin deficiency. Pathology 41 (2009), 388–392.
85. 85. Wachino, J., Arakawa, Y., Exogenously acquired 16S rRNA methyltransferases found in aminoglycoside-resistant pathogenic Gram-negative bacteria: an update. Drug Resist Updat 15 (2012), 133–148.
86. 86. Partridge, S.R., Tsafnat, G., Coiera, E., et al. Gene cassettes and cassette arrays in mobile resistance integrons. FEMS Microbiol Rev 33 (2009), 757–784.
87. 87. Ramirez, M.S., Tolmasky, M.E., Aminoglycoside modifying enzymes. Drug Resist Updat 13 (2010), 151–171.
88. 88. Shaw, K.J., Rather, P.N., Hare, R.S., et al. Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes. Microbiol Rev 57 (1993), 138–163.
89. 89. Karim, A., Poirel, L., Nagarajan, S., et al. Plasmid-mediated extended-spectrum β-lactamase (CTX-M-3 like) from India and gene association with insertion sequence ISEcp1. FEMS Microbiol Lett 201 (2001), 237–241.
90. CTX-M within an Australian extended-spectrum β-lactamase gene pool. Antimicrob Agents Chemother 52 (2008), 4198–4202.
91. 91. Nordmann, P., Poirel, L., Walsh, T.R., et al. The emerging NDM carbapenemases. Trends Microbiol 19 (2011), 588–595.
92. 92. Chu, Y.W., Afzal-Shah, M., Houang, E.T., et al. IMP-4, a novel metallo-β-lactamase from nosocomial Acinetobacter spp. collected in Hong Kong between 1994 and 1998. Antimicrob Agents Chemother 45 (2001), 710–714.
93. 93. Hawkey, P.M., Xiong, J., Ye, H., et al. Occurrence of a new metallo-β-lactamase IMP-4 carried on a conjugative plasmid in Citrobacter youngae from the People's Republic of China. FEMS Microbiol Lett 194 (2001), 53–57.
94. IMP-4 in different genetic contexts in Enterobacteriaceae isolates from Australia. Antimicrob Agents Chemother 52 (2008), 2984–2987.
95. 95. Peleg, A.Y., Franklin, C., Bell, J., et al. Emergence of IMP-4 metallo-β-lactamase in a clinical isolate from Australia. J Antimicrob Chemother 54 (2004), 699–700.
96. 96. Espedido, B., Iredell, J., Thomas, L., et al. Wide dissemination of a carba-penemase plasmid among Gram-negative bacteria: implications of the variable phenotype. J Clin Microbiol 43 (2005), 4918–4919.
97. 97. Roy Chowdhury, P., Ingold, A., Vanegas, N., et al. Dissemination of multiple drug resistance genes by class 1 integrons in Klebsiella pneumoniae isolates from four countries: a comparative study. Antimicrob Agents Chemother 55 (2011), 3140–3149.
98. 98. Xiao, Y., Hu, Y., The major aminoglycoside-modifying enzyme AAC(3)-II found in Escherichia coli determines a significant disparity in its resistance to gentamicin and amikacin in China. Microb Drug Resist 18 (2012), 42–46.
99. 99. Doi, Y., Arakawa, Y., 16S ribosomal RNA methylation: emerging resistance mechanism against aminoglycosides. Clin Infect Dis 45 (2007), 88–94.
100. NDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother 53 (2009), 5046–5054.
101. 101. Yigit, H., Queenan, A.M., Anderson, G.J., et al. Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 45 (2001), 1151–1161.
102. 102. Coatsworth, N.R., Huntington, P.G., Hardiman, R.P., et al. A case of carbapenemase-producing Klebsiella pneumoniae in Australia. Pathology 44 (2012), 42–44.
103. 103. Poirel, L., Lagrutta, E., Taylor, P., et al. Emergence of metallo-β-lactamase NDM-1-producing multidrug-resistant Escherichia coli in Australia. Antimicrob Agents Chemother 54 (2010), 4914–4916.
104. 104. Sidjabat, H., Nimmo, G.R., Walsh, T.R., et al. Carbapenem resistance in Klebsiella pneumoniae due to the New Delhi metallo-β-lactamase. Clin Infect Dis 52 (2011), 481–484.
105. 105. Jain, A., Hopkins, K.L., Turton, J., et al. NDM carbapenemases in the United Kingdom: an analysis of thefirst 250 cases. J Antimicrob Chemother, 69, 1777, 84.
106. 106. Woodford, N., Zhang, J., Warner, M., et al. Arrival of Klebsiella pneumoniae producing KPC carbapenemase in the United Kingdom. J Antimicrob Chemother 62 (2008), 1261–1264.
107. 107. van Hal, S.J., Wiklendt, A., Espedido, B., et al. Immediate appearance of plasmid-mediated resistance to multiple antibiotics upon antibiotic selection: an argument for systematic resistance epidemiology. J Clin Microbiol 47 (2009), 2325–2327.
108. 108. Rockett, R.J., Tozer, S.J., Peatey, C., et al. A real-time, quantitative PCR method using hydrolysis probes for the monitoring of Plasmodium falciparum load in experimentally infected human volunteers. Malar J, 10, 2011, 48.
109. 109. Nwakanma, D.C., Gomez-Escobar, N., Walther, M., et al. Quantitative detection of Plasmodium falciparum DNA in saliva, blood, and urine. J Infect Dis 199 (2009), 1567–1574.
110. 110. Ferreira, I.D., Rosario, V.E., Real-time quantitative PCR with SYBR Green I detection for estimating copy numbers of nine drug resistance candidate genes in Plasmodium falciparum. Malar J, 5, 2006, 1.
111. 111. Gullett, J.C., Nolte, F.S., Quantitative nucleic acid amplification methods for viral infections. Clin Chem 61 (2015), 72–78.
112. 112. Tsubota, A., Arase, Y., Someya, T., et al. Early viral kinetics and treatment outcome in combination of high-dose interferon induction vs. pegylated interferon plus ribavirin for naive patients infected with hepatitis C virus of genotype 1b and high viral load. J Med Virol 75 (2005), 27–34.
113. 113. Kotton, C.N., Kumar, D., Caliendo, A.M., et al. Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation. Transplantation 96 (2013), 333–360.
114. 114. Ferenci, P., Laferl, H., Scherzer, T.M., et al. Peginterferon alfa-2a and ribavirin for 24 weeks in hepatitis C type 1 and 4 patients with rapid virological response. Gastroenterology 135 (2008), 451–458.
115. 115. Ghany, M.G., Strader, D.B., Thomas, D.L., et al. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 49 (2009), 1335–1374.
116. 116. Jensen, D.M., Morgan, T.R., Marcellin, P., et al. Early identification of HCV genotype 1 patients responding to 24 weeks peginterferon α-2a (40 kd)/ribavirin therapy. Hepatology 43 (2006), 954–960.
117. 117. World Health Organization (WHO). Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection, 2013, WHO, Geneva.
118. 118. Baggaley, R.F., Griffin, J.T., Chapman, R., et al. Estimating the public health impact of the effect of herpes simplex virus suppressive therapy on plasma HIV-1 viral load. AIDS 23 (2009), 1005–1013.
119. 119. Sahu, G.K., Potential implication of residual viremia in patients on effective antiretroviral therapy. AIDS Res Hum Retroviruses 31 (2015), 25–35.
120. 120. Alvarez Estevez, M., Chueca Porcuna, N., Guillot Suay, V., et al. Quantification of viral loads lower than 50 copies per milliliter by use of the Cobas AmpliPrep/Cobas TaqMan HIV-1 test, version 2.0, can predict the likelihood of subsequent virological rebound to >50 copies per milliliter. J Clin Microbiol 51 (2013), 1555–1557.
121. 121. Doyle, T., Smith, C., Vitiello, P., et al. Plasma HIV-1 RNA detection below 50 copies/ml and risk of virologic rebound in patients receiving highly active antiretroviral therapy. Clin Infect Dis 54 (2012), 724–732.
122. 122. Pascual-Pareja, J.F., Martinez-Prats, L., Luczkowiak, J., et al. Detection of HIV-1 at between 20 and 49 copies per milliliter by the Cobas TaqMan HIV-1 v2.0 assay is associated with higher pretherapy viral load and less time on antiretroviral therapy. J Clin Microbiol 48 (2010), 1911–1912.
123. 123. Dellinger, R.P., Levy, M.M., Carlet, J.M., et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 36 (2008), 296–327.
124. 124. Kumar, A., Roberts, D., Wood, K.E., et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34 (2006), 1589–1596.
125. 125. Rivers, E., Nguyen, B., Havstad, S., et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345 (2001), 1368–1377.
126. 126. Bhat, S.V., Peleg, A.Y., Lodise, T.P. Jr., et al. Failure of current cefepime breakpoints to predict clinical outcomes of bacteremia caused by Gramnegative organisms. Antimicrob Agents Chemother 51 (2007), 4390–4395.
127. 127. Ibrahim, E.H., Sherman, G., Ward, S., et al. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 118 (2000), 146–155.
128. 128. Kumar, A., Haery, C., Paladugu, B., et al. The duration of hypotension before the initiation of antibiotic treatment is a critical determinant of survival in a murine model of Escherichia coli septic shock: association with serum lactate and inflammatory cytokine levels. J Infect Dis 193 (2006), 251–258.
129. 129. Rangel-Frausto, M.S., Pittet, D., Costigan, M., et al. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 273 (1995), 117–123.
130. 130. Hackett, S.J., Guiver, M., Marsh, J., et al. Meningococcal bacterial DNA load at presentation correlates with disease severity. Arch Dis Child 86 (2002), 44–46.
131. 131. Rello, J., Lisboa, T., Lujan, M., et al. Severity of pneumococcal pneumonia associated with genomic bacterial load. Chest 136 (2009), 832–840.
132. 132. Martínez, J.A., Soto, S., Fabrega, A., et al. Relationship of phylogenetic background, biofilm production, and time to detection of growth in blood culture vials with clinical variables and prognosis associated with Escherichia coli bacteremia. J Clin Microbiol 44 (2006), 1468–1474.
133. 133. Liao, C.H., Lai, C.C., Hsu, M.S., et al. Correlation between time to positivity of blood cultures with clinical presentation and outcomes in patients with Klebsiella pneumoniae bacteraemia: prospective cohort study. Clin Microbiol Infect 15 (2009), 1119–1125.